Kelly Elizabeth Dyer
NRSA Postdoctoral Fellow of Medicine (Infectious Diseases)
Department: Medicine
Contact information
Medical Arts Building
Penn Presbyterian Medical Center
Philadelphia, PA 19104
Penn Presbyterian Medical Center
Philadelphia, PA 19104
Education:
BS (Neuroscience and Behavioral Biology)
Emory University School of Medicine, 2013.
MD (Medicine)
Emory University School of Medicine, 2019.
MSHP (Health Policy Research)
University of Pennsylvania, 2025.
Permanent linkBS (Neuroscience and Behavioral Biology)
Emory University School of Medicine, 2013.
MD (Medicine)
Emory University School of Medicine, 2019.
MSHP (Health Policy Research)
University of Pennsylvania, 2025.
Description of Clinical Expertise
HIV, HIV Prevention, Viral Hepatitis, The Syndemic of Substance Use Disorder and Infectious Disease, Sexually Transmitted Infections, Bacterial Infection, Fungal Infections, Viral InfectionsDescription of Research Expertise
Health Policy and Health Services Research, Quality Improvement, Implementation ScienceSelected Publications
Kelly Dyer: Substance Use Disorder and HIV/AIDS: Addressing Dual Crises [Interview] American Journal of Managed Care August 2024 Notes: https://www.ajmc.com/view/substance-use-disorder-and-hiv-aids-addressing-dual-crises.Dyer K, Sabetan S, Bourbeau M, Yang W-T, Torgerson J, Aitcheson N: Integration of comprehensive infectious disease screening within an inpatient detoxification unit in Philadelphia: Capitalizing on engagement opportunities to reduce harm and improve patient outcomes. 25th International AIDS Conference July 2024 Notes: Munich, Germany (Virtual).
Leekha S, Robinson G.L, Jacob J.T, Fridkin S, Shane A, Sick-Samuels A, Milstone AM, Nair R, Perencevich E, Puig-Asensio M, Kobayashi T, Mayer J, Lewis J, Bleasdale S, Wenzler E, Mena Lora AJ, Baghdadi J, Schrank GM, Wilber E, Aldredge AA, Sharp J, Dyer KE, Kendrick L, Ambalam V, Borgetti S, Carmack A, Gushiken A, Patel A, Reddy S, Brown CH, Dantes RB, Harris AD: Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study. BMJ Quality and Safety 8: 487-498, 7 2024.
Dyer K, Russel R, Nafiz R, Burdick-McPhee A, O’Neal J, Mason T, Kuncio D, Zellman H, Lo Re V, Torgersen J: Opt-Out Infectious Disease Screening within an Inpatient Substance Use Treatment Program: Opportunities for Infection Prevention and Expedited Care. oral presentation at The 12th International Conference on Health and Hepatitis in Substance Users 10 2024 Notes: Athens, Greece.
Loeven N, Altneu E, Spivack S, Halpern-Cohen V, Dyer K, Sullivan K, Epstein S, Teixera da Silva D, Meisner J, Schultz S: Increase in iGAS seen at two urban quaternary care centers in Philadelphia: Association with PWID and the unstably housed. ID Week October 2023.
Jones MD, Dyer K, Nedell ER, Fletcher MR, Grimsley Ackerley C, Hussen SA, Kalokhe AS: One size does not fit all: Preferences for HIV care delivery among out-of-care people living with HIV in the Southeastern United States. PloS One 18(1), January 2023.
Loeven N, Dyer K, Halpern-Cohen V, Comar C, Meisner J, Glaser L: Macrolide and lincosamide susceptibility profiles and use of clindamycin for iGAS in one hospital in Philadelphia. ASM Microbe 2023.
Dyer KE, Jones MD, Fletcher MR, Grimsley Ackerly C, Hussen SA, Nedell ER, Kalokhe AS: One Size Does Not Fit All: Preferences for HIV Care Delivery Among Out-of-Care People Living with HIV in the United States. 11th International AIDS Society Conference on HIV Science July 2021 Notes: Berlin, Germany (Virtual)).
Dyer K, del Rio C, Colasanti J: Provider Experience with Implementation and Delivery of Pre-Exposure Prophylaxis (PrEP) in Clinical Practice: A Survey of Atlanta’s HIV Providers. SGIM Southern Regional Conference February 2021.
Dyer K, Vettese TE: Unexplained Symptomatic Paroxysmal Hypertension: a Diagnostic and Management Challenge. J Gen Intern Med 35(2): e0276852, Februrary 2020.